Microbes will always triumph over antibiotics. We can only choose the battles that will make a difference
AS A species, we have evolved into killing machines extraordinaire. For us, killing is not just a matter of self-preservation, an instinct shared by all creatures that defend themselves with whatever weapons nature has blessed them with—poison, horns, incisors or claws. Armed with a supernatural arsenal, we now don’t merely disable or kill; we aim to annihilate, be it termites, weeds, mosquitoes, cancer cells, or, going by Trump’s “fire and fury” bluster, even fellow human beings.
Antibiotics are part of that arsenal and were designed to annihilate bad bacteria. Whenever we fall sick, doctors order them as a matter of routine. We are duly advised to complete the course, which usually lasts in multiples of five to seven days, lest some bacteria survive the attack, and mutate, thereby becoming immune to the drug. Not sticking to this dogma, according to the medical establishment, is one of the reasons behind the crisis of antibiotic resistance.
Intriguingly, it now turns out that this widely-held dogma has no scientific basis. In a recent edition of the British Medical Journal, medical researchers at Brighton and Sussex medical school claim that “the idea that stopping antibiotic treatment early encourages antibiotic resistance is not supported by evidence, while taking antibiotics for longer than necessary increases the risk of resistance.” The heretics believe we are better off opting out the moment we feel better.
This heresy does have some backers, but not yet large enough to inspire a paradigm shift and make doctors change tack. Meanwhile, the crisis of antimicrobial resistance (AMR) continues to spiral from grave to critical. According to The Review on Antimicrobial Resistance commissioned by the UK government, by 2050, every year, AMR is likely to claim 317,000 lives in North America, 390,000 in Europe and over 4 million in Asia and Africa.
この記事は Down To Earth の September 1, 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Down To Earth の September 1, 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.